Article
ANNALS OF ONCOLOGY  (2024)

Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study

Lorusso, Domenica; Colombo, Nicoletta; Dubot, C.; Cáceres, M.V.; Hasegawa, K.; Shapira-Frommer, R.; Salman, Pamela; Yañez, E; Gümü?, M.; Olivera Hurtado de Mendoza, M. et al.